Bank of Montreal’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-419
| Closed | -$1K | – | 4463 |
|
|
2020
Q1 | $1K | Sell |
419
-13,505
| -97% | -$32.2K | ﹤0.01% | 3719 |
|
|
2019
Q4 | $71K | Buy |
13,924
+4,023
| +41% | +$20.5K | ﹤0.01% | 3152 |
|
|
2019
Q3 | $50K | Sell |
9,901
-2,385
| -19% | -$12K | ﹤0.01% | 3146 |
|
|
2019
Q2 | $76K | Buy |
12,286
+10,002
| +438% | +$61.9K | ﹤0.01% | 3047 |
|
|
2019
Q1 | $11K | Buy |
2,284
+1,088
| +91% | +$5.24K | ﹤0.01% | 3455 |
|
|
2018
Q4 | $5K | Buy |
1,196
+613
| +105% | +$2.56K | ﹤0.01% | 3763 |
|
|
2018
Q3 | $4K | Buy |
583
+56
| +11% | +$384 | ﹤0.01% | 3869 |
|
|
2018
Q2 | $4K | Buy |
+527
| New | +$4K | ﹤0.01% | 3874 |
|
|
2017
Q2 | – | Sell |
-1,481
| Closed | -$14K | – | 3935 |
|
|
2017
Q1 | $14K | Buy |
+1,481
| New | +$14K | ﹤0.01% | 3203 |
|
|
2016
Q1 | – | Sell |
-17,316
| Closed | -$106K | – | 4111 |
|
|
2015
Q4 | $106K | Buy |
17,316
+4,859
| +39% | +$29.7K | ﹤0.01% | 2574 |
|
|
2015
Q3 | $71K | Sell |
12,457
-3,030
| -20% | -$17.3K | ﹤0.01% | 2560 |
|
|
2015
Q2 | $116K | Buy |
15,487
+6,100
| +65% | +$45.7K | ﹤0.01% | 2472 |
|
|
2015
Q1 | $56K | Buy |
+9,387
| New | +$56K | ﹤0.01% | 2666 |
|
|
2014
Q3 | – | Sell |
-1,720
| Closed | -$7K | – | 4037 |
|
|
2014
Q2 | $7K | Buy |
+1,720
| New | +$7K | ﹤0.01% | 3615 |
|